These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4936992)

  • 41. Augmentation of hepatic blood flow by acetylcholine.
    Wangensteen SL; Ludewig RM; Madden JJ
    Am J Surg; 1970 May; 119(5):510-4. PubMed ID: 5441740
    [No Abstract]   [Full Text] [Related]  

  • 42. [Experimental studies concerning about the effects of the portal arterialization 4 weeks after ligation of hepatic artery under the optimal arterio-portal shunt blood flow].
    Sato K
    Hokkaido Igaku Zasshi; 1997 Sep; 72(5):491-501. PubMed ID: 9363466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the measurement of the renal blood flow by the 133 Xe washout technique in dogs.
    Kahn RJ; Gottignies P; Vanherweghem JL; Lambert PP
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):389-94. PubMed ID: 4562452
    [No Abstract]   [Full Text] [Related]  

  • 44. The clearance of Xenon-133 following its parenchymal injection: a rapid method for estimating functional liver blood-flow.
    Jenkins SA; Taylor A; Shimirty SK; Johnson J; Baxter JN; Taylor I; Shields R
    Clin Physiol; 1985 Oct; 5(5):433-42. PubMed ID: 4053526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of route of hepatic administration on drug availability.
    Ahmad AB; Bennett PN; Rowland M
    J Pharmacol Exp Ther; 1984 Sep; 230(3):718-25. PubMed ID: 6470976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The metabolic response of the liver to portacaval shunt.
    Smith GW; Mouzas GL
    Surgery; 1970 Aug; 68(2):341-9. PubMed ID: 5450715
    [No Abstract]   [Full Text] [Related]  

  • 47. Values for intrarenal distribution of blood flow using xenon-133 in the anesthetized dog.
    Bovee KC; Webster GD
    Am J Vet Res; 1972 Mar; 33(3):501-9. PubMed ID: 5014458
    [No Abstract]   [Full Text] [Related]  

  • 48. Experimental augmentation of hepatic blood flow.
    Smith GW; Zug RC; Teague FB; Muller WH
    Rev Int Hepatol; 1966; 16(4):937-47. PubMed ID: 5919742
    [No Abstract]   [Full Text] [Related]  

  • 49. Coronary flow determination in experimental conditions with the use of radioactive Xenon ( 133 Xe).
    Kraska T; Kupść W; Serzysko W; Szczerbań J; Zochowski RJ
    Pol Med J; 1972; 11(1):49-58. PubMed ID: 4557334
    [No Abstract]   [Full Text] [Related]  

  • 50. The rôle of beta-receptors in the regulation of the arterial circulation of the liver.
    Fischer A; Takács L; Bencsáth P; Vaslaki L
    Acta Hepatosplenol; 1970; 17(6):411-5. PubMed ID: 5490558
    [No Abstract]   [Full Text] [Related]  

  • 51. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
    Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
    Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Measurement method of total hepatic outflow with radioactive xenon].
    Amiel M; Espinasse P; Rubet A
    J Radiol Electrol Med Nucl; 1970 Nov; 51(11):683-4. PubMed ID: 5489114
    [No Abstract]   [Full Text] [Related]  

  • 53. A comparison of xenon-133 clearance with electromagnetic flowmeters and an indicator dilution method for the measurement of liver blood flow.
    Thorne J; Bennett R; Shields R; Johnson J; Taylor I
    Br J Surg; 1979 Jun; 66(6):385-8. PubMed ID: 157180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New measurement of hepatic blood flow by xenon CT system: an animal study with PGE1.
    Hayashi S; Dono K; Shimizu J; Murakami T; Takamura M; Kim T; Hori M; Lu Z; Nagano H; Nakamori S; Sakon M; Nakamura H; Monden M
    J Surg Res; 2005 Nov; 129(1):24-30. PubMed ID: 16243046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Xenon 133 clearance from dog hind limb muscle after infusion of low molecular weight dextran.
    Filo RS; Fry WJ
    Rev Surg; 1972; 29(3):225-6. PubMed ID: 4554260
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatic arterial buffer response fails to restore hepatic oxygenation after temporary liver dearterialization in canines.
    Cruz RJ; Ribeiro EA; Poli de Figueiredo LF; Cantos OR; Rocha e Silva M
    Transplant Proc; 2005 Dec; 37(10):4560-2. PubMed ID: 16387170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The afferent circulation of the transplanted liver during the recirculatory phase in dogs.
    Jakab F; Sugár I; Ráth Z; Nagy P; Faller J
    Acta Chir Hung; 1994; 34(1-2):69-78. PubMed ID: 7604631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
    Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
    Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A dye dilution study of the hepatic circulation during Staphylococcus toxin shock.
    Vetto RM; Belzer FO; Rogers RC; Page US; Robertson KA
    Surg Gynecol Obstet; 1965 Dec; 121(6):1263-8. PubMed ID: 5322037
    [No Abstract]   [Full Text] [Related]  

  • 60. Measurement of dual hepatic blood flow in awake patients.
    Strandell T; Erwald R; Kulling KG; Lundbergh P; Marions O; Wiechel KL
    J Appl Physiol; 1973 Nov; 35(5):755-61. PubMed ID: 4588965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.